This report is being submitted retrospectively as part of an internal review.A review of the device's manufacturing records revealed that the sensor lot met all requirements including sterilization requirements for release.Inability to remove sensor is a known and anticipated potential adverse effect, which does not require additional investigation by manufacturer.Tissue growth around the sensor is an expected phenomenon and the sensor is designed to be biocompatible.The regular doctor could not grasp the sensor because of fused tissue and hence asked patient to go to the hospital to have a surgeon remove it.No emergency services were called nor patient required any hospitalization.The sensor was successfully removed by the surgeon and incision site was sutured.Per case information, patient is doing well and currently using eversense xl cgm system with up to date glucose information.There is no remedial action/corrective action/preventive action/field safety corrective action required.
|